Related references
Note: Only part of the references are listed.Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones
Agnes-Laurence Chenine et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections
Kshitij Wagh et al.
PLOS PATHOGENS (2018)
Passive immunotherapy of viral infections: 'super-antibodies' enter the fray
Laura M. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2018)
HIV surveillance combining an assay for identification of very recent infection and phylogenetic analyses on dried spots
Denys Brand et al.
AIDS (2017)
The HIV-1 envelope glycoprotein structure: nailing down a moving target
Andrew B. Ward et al.
IMMUNOLOGICAL REVIEWS (2017)
Identification and specificity of broadly neutralizing antibodies against HIV
Laura E. McCoy et al.
IMMUNOLOGICAL REVIEWS (2017)
Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments
Peter Hraber et al.
JOURNAL OF VIROLOGY (2017)
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Marina Caskey et al.
NATURE MEDICINE (2017)
Probing the compartmentalization of HIV-1 in the central nervous system through its neutralization properties
Karl Stefic et al.
PLOS ONE (2017)
Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies
Antoine Chaillon et al.
RETROVIROLOGY (2017)
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
Ling Xu et al.
SCIENCE (2017)
How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design
Marie Pancera et al.
CURRENT OPINION IN HIV AND AIDS (2017)
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity
Yaoxing Huang et al.
CELL (2016)
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
Jinghe Huang et al.
IMMUNITY (2016)
Determinants of HIV-1 broadly neutralizing antibody induction
Peter Rusert et al.
NATURE MEDICINE (2016)
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
K. J. Bar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
Rui Kong et al.
SCIENCE (2016)
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization
Cecilia Rademeyer et al.
PLOS PATHOGENS (2016)
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C
Kshitij Wagh et al.
PLOS PATHOGENS (2016)
Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA
Moussa Laanani et al.
CLINICAL INFECTIOUS DISEASES (2015)
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey et al.
NATURE (2015)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes
Rui Kong et al.
JOURNAL OF VIROLOGY (2015)
Characteristics of Patients Recently Infected with HIV-1 Non-B Subtypes in France: a Nested Study within the Mandatory Notification System for New HIV Diagnoses
Denys Brand et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Allan deCamp et al.
JOURNAL OF VIROLOGY (2014)
Drift of the HIV-1 Envelope Glycoprotein gp120 toward Increased Neutralization Resistance over the Course of the Epidemic: a Comprehensive Study Using the Most Potent and Broadly Neutralizing Monoclonal Antibodies
M. Bouvin-Pley et al.
JOURNAL OF VIROLOGY (2014)
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor
Amarendra Pegu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Antibody B cell responses in HIV-1 infection
Hugo Mouquet
TRENDS IN IMMUNOLOGY (2014)
Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike
Louise Scharf et al.
CELL REPORTS (2014)
Increasing HIV-1 Non-B Subtype Primary Infections in Patients in France and Effect of HIV Subtypes on Virological and Immunological Responses to Combined Antiretroviral Therapy
Marie-Laure Chaix et al.
CLINICAL INFECTIOUS DISEASES (2013)
Residue-Level Prediction of HIV-1 Antibody Epitopes Based on Neutralization of Diverse Viral Strains
Gwo-Yu Chuang et al.
JOURNAL OF VIROLOGY (2013)
Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues
Anthony P. West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Antibodies in HIV-1 Vaccine Development and Therapy
Florian Klein et al.
SCIENCE (2013)
Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic
Melanie Bouvin-Pley et al.
PLOS PATHOGENS (2013)
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
Peter D. Kwong et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Previously Transmitted HIV-1 Strains Are Preferentially Selected During Subsequent Sexual Transmissions
Andrew D. Redd et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Refined Identification of Neutralization-Resistant HIV-1 CRF02_AG Viruses
Rajesh Abraham Jacob et al.
JOURNAL OF VIROLOGY (2012)
Broadly Neutralizing Antibodies Developed by an HIV-Positive Elite Neutralizer Exact a Replication Fitness Cost on the Contemporaneous Virus
D. Noah Sather et al.
JOURNAL OF VIROLOGY (2012)
A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies
Nicole A. Doria-Rose et al.
JOURNAL OF VIROLOGY (2012)
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang et al.
NATURE (2012)
Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape
Penny L. Moore et al.
NATURE MEDICINE (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
Brian Moldt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
Hugo Mouquet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Global trends in molecular epidemiology of HIV-1 during 2000-2007
Joris Hemelaar et al.
AIDS (2011)
Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
Yuxing Li et al.
JOURNAL OF VIROLOGY (2011)
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Jason S. McLellan et al.
NATURE (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
Ron Diskin et al.
SCIENCE (2011)
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid et al.
SCIENCE (2011)
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
Michael S. Seaman et al.
JOURNAL OF VIROLOGY (2010)
Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level
Evelien M. Bunnik et al.
NATURE MEDICINE (2010)
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Tongqing Zhou et al.
SCIENCE (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0
Stephane Guindon et al.
SYSTEMATIC BIOLOGY (2010)
Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strain
Martine Braibant et al.
VIROLOGY (2010)
Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission
Manish Sagar et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
Melissa D. Simek et al.
JOURNAL OF VIROLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection
Evelien M. Bunnik et al.
JOURNAL OF VIROLOGY (2008)
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in southern Africa
Ming Li et al.
JOURNAL OF VIROLOGY (2006)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines
BK Brown et al.
JOURNAL OF VIROLOGY (2005)
Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission
CA Derdeyn et al.
SCIENCE (2004)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
DD Richman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
Antiviral activity of the neutralizing antibodies 2F5 and 2612 in asymptomatic HIV-1-infected humans:: a phase I evaluation
G Stiegler et al.
AIDS (2002)
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41
MB Zwick et al.
JOURNAL OF VIROLOGY (2001)
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
JR Mascola et al.
NATURE MEDICINE (2000)
Share Paper
